Signaling mismatch repair in cancer

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1239-1241

  Fishel, Richard ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

APOPTOSIS; BASE MISPAIRING; CANCER; CANCER DIAGNOSIS; CANCER GROWTH; COLORECTAL CANCER; DNA METHYLATION; DNA REPAIR; ENDOMETRIUM CANCER; GENE MUTATION; GERM LINE; MICROSATELLITE INSTABILITY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

ANIMALS; BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; DNA-BINDING PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0032723363     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15191     Document Type: Short Survey

References (17)

1. Bocker, T., Ruschoff, J. & Fishel, R. Molecular diagnostics of cancer predisposition: hereditary nonpolyposis colorectal carcinoma and mismatch repair defects. Biochim. Biophys. Acta 31, 1-10 (1999).
2. Dietmaier, W. et al. Diagnostic microsatellite instability - definition and correlation with mismatch repair protein expression. Cancer Res. 57, 4749-4756 (1997).
3. de Wind, et al. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch repair protein functions. Nature Gen. 23, 359-362 (1999).
4. Wijnen, J., et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nature Gen. 23, 142-144.
5. Kolodner, et al. Germline MSH6 mutation in colorectal cancer families. Cancer Res. 59, 5068-5074 (1999).
6. Gradia, S., Acharya, S. & Fishel, R. The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch. Cell. 91, 995-1005 (1997).
7. Fishel, R. Mismatch repair, molecular switches, and signal transduction. Genes and Dev. 12, 2096-2101 (1998).
8. Gradia, S. et al. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol. Cell 3, 255-261 (1999).
9. Loeb, L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075-3079 (1991).
10. Aebi, S. et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56, 3087-3090 (1996).
11. Karran, P. & Bignami, M. Self-distruction and tolerance in resistance of mammalian cells to alkylation damage. Nucl. Acids Res. 20, 2933-2940 (1992).
12. Davis, T.W. et al. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res. 58, 767-778 (1998).
13. Edelmann, W. et al. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 91, 467-477 (1997).
14. Ruschoff, J. et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc. Natl. Acad. of Sci. USA 95, 11301-11306 (1998).
15. Zhang, H. et al. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res. 59, 3021-3027 (1999).
16. Akiyama, Y. et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 57, 3920-3923 (1997).
17. Miyaki, M. et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Gen. 17, 271-272 (1997).